Kawasaki Disease: An Acute Inflammatory Condition Primarily Affecting Young Children

Kawasaki disease is an acute inflammatory condition that primarily affects young children. It was first described in 1967 by Japanese pediatrician Tomisaku Kawasaki, after whom it is named. Kawasaki disease is characterized by inflammation of the walls of medium-sized blood vessels (vasculitis) in the body.

What is Kawasaki disease and what are its causes?

The main characteristics of Kawasaki disease include:

• Persistent fever, usually above 39°C, lasting at least 5 days;
• Skin rashes;
• Swollen lymph nodes in the neck;
• Redness and swelling of the hands and feet;
• Bilateral conjunctivitis (red eyes);
• Changes in the mouth and tongue (red, cracked lips, “strawberry” tongue).

Although Kawasaki disease can affect children of any age, approximately 85% of cases occur in children under 5 years old, with a peak incidence between 18-24 months. The condition is more common in boys than in girls.

Regarding the causes, they are not fully understood. Researchers believe that Kawasaki syndrome may be triggered by a combination of factors, such as:

• Infectious agents (viruses or bacteria) that cause an abnormal immune response in genetically predisposed individuals;
• Genetic factors that increase the susceptibility of some children;
• As yet unidentified environmental factors.

Although various microorganisms (adenoviruses, coronaviruses, streptococci) have been suspected, no clear causal link between them and Kawasaki disease has been demonstrated to date. The condition does not appear to be contagious, but it can occur in community outbreaks, suggesting a possible common trigger.

It is important to note that Kawasaki disease is one of the leading causes of acquired heart disease in children under 5 years old in developed countries. The inflammation can affect the coronary arteries, leading to the formation of aneurysms. However, with early diagnosis and appropriate treatment, most children recover completely without long-term complications. A natural product that deserves special attention is Aronia and Siberian Blueberry Juice 3L ECO. This organic juice combines the beneficial properties of two super-fruits.

Aronia (Aronia melanocarpa): Known for its high content of antioxidants, especially anthocyanins and polyphenols. These substances have strong anti-inflammatory properties and can help protect cells against oxidative stress.

Siberian Blueberry (Lonicera caerulea): Rich in vitamin C and anthocyanins, this fruit helps strengthen the immune system and also has anti-inflammatory properties.

[cta_produs style=”style_1″ product=”147599″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/02/Importanta-unei-alimentatii-sanatoase-in-prevenirea-si-gestionarea-bolilor-inflamatorii_Suc-de-Aronia-si-Afin-Siberian-la-3L-ECO.jpg”]

Regular consumption of aronia and siberian blueberry juice can bring the following health benefits, such as:

• Immune system support;
• Reduction of systemic inflammation;
• Antioxidant protection;
• Improvement of cardiovascular health;
• Support of cognitive function.

Symptoms of Kawasaki disease – from red lips in children to palm erythema

Understanding the symptoms of Kawasaki disease is crucial for the early diagnosis and treatment of this condition. The disease manifests through several characteristic symptoms that usually appear in stages. The main signs and symptoms include:

• Persistent fever, usually above 39°C, lasting at least 5 days;
• Skin rash with a varied appearance, especially on the trunk and genital area;
• Palmar erythema – redness and swelling of the palms and soles;
• Bilateral conjunctivitis (red eyes) without discharge;
• Red lips in children, dry and cracked;
• “Strawberry” tongue with prominent papillae;
• Enlarged lymph node in the neck, usually unilateral.

In the first phase of the child’s illness, which can last up to 2 weeks, the following symptoms usually appear:

• High and persistent fever;
• Extreme irritability;
• Skin rash;
• Red eyes;
• Inflamed lips, tongue, and oral mucosa;
• Swollen and red palms and soles.

In the second phase, which begins after 1-2 weeks, the following may occur:

• Peeling of the skin on the fingertips;
• Joint pain;
• Diarrhea;
• Vomiting;
• Abdominal pain.

It is important for parents to be attentive to these symptoms and consult a doctor if they notice persistent fever accompanied by other signs specific to Kawasaki disease. Early diagnosis and treatment are essential to prevent potential cardiac complications.

Diagnosis of Kawasaki disease

The diagnostic process for Kawasaki disease is complex and is primarily based on clinical evaluation, as there is no specific test for this condition. The doctor will look for the presence of the following diagnostic criteria:

• Persistent fever for at least 5 days;
• At least 4 of the following 5 main symptoms:
  • Bilateral conjunctivitis without discharge;
  • Changes in the oral mucosa and tongue;
  • Polymorphic skin rash;
  • Erythema and edema of the palms and soles, followed by peeling;
  • Cervical lymphadenopathy.

To confirm the diagnosis and rule out other conditions, the doctor will recommend the following investigations:

• Blood tests:
  • Complete blood count – may show anemia and an increase in white blood cell count;
  • ESR and C-reactive protein – markers of inflammation, usually elevated;
  • Liver enzymes – may be mildly elevated.
• Cardiological investigations:
  • Electrocardiogram (ECG);
  • Echocardiogram – essential for evaluating the coronary arteries and detecting potential aneurysms.

In atypical or incomplete cases of Kawasaki disease, when not all clinical criteria are met, the diagnosis may be supported by the presence of suggestive echocardiographic changes.

The doctor will rule out other conditions with similar symptoms, such as:

• Scarlet fever;
• Stevens-Johnson syndrome;
• Measles;
• Viral infections.

It is important to note that the vasculitis characteristic of Kawasaki disease can also affect the blood vessels in the lower limbs. Although less common, skin manifestations may occur on the feet in the form of edema, erythema, or peeling.

Early and correct diagnosis of Kawasaki disease is essential for prompt initiation of treatment and prevention of potentially severe cardiac complications.

Treatment and management of Kawasaki disease

Once the diagnosis of Kawasaki disease is confirmed, treatment should be initiated as soon as possible to reduce the risk of complications. The main objectives of therapy are:

• Reducing vascular inflammation;
• Preventing the formation of coronary aneurysms;
• Alleviating acute symptoms.

Standard treatment for Kawasaki disease includes:

1. Intravenous immunoglobulin (IVIG) – administered in a high dose, in a single infusion, within the first 10 days of fever onset. IVIG helps significantly reduce the risk of coronary complications.
2. Acetylsalicylic acid (aspirin) – initially in high doses for its anti-inflammatory effect, then in low doses for its antiplatelet effect. The duration of administration depends on clinical evolution and the presence of potential aneurysms.

In cases that do not respond to initial IVIG treatment, the following may be used:

• A second dose of IVIG;
• Corticosteroids (e.g., intravenous methylprednisolone);
• Biologic therapies (TNF-α or IL-1 inhibitors).

Long-term management of patients with Kawasaki syndrome includes:

• Periodic cardiological monitoring through echocardiography;
• Assessment of cardiovascular risk factors;
• Counseling on a healthy lifestyle.

For patients who develop persistent coronary aneurysms, long-term anticoagulation or even coronary revascularization procedures may be necessary in severe cases.

Although most children recover completely after appropriate treatment, long-term follow-up of all patients diagnosed with Kawasaki disease is essential, even in the absence of acute complications.

Possible complications of Kawasaki disease

Despite prompt and adequate treatment, Kawasaki disease can lead to severe complications in some cases. It is crucial to understand these potential complications to ensure close monitoring and prompt intervention when needed. The main possible complications include:

• Coronary artery aneurysms – This is the most serious complication of Kawasaki disease. Inflammation can lead to the dilation and thinning of the coronary artery walls, forming aneurysms. In severe cases, these can cause:
  • Coronary thrombosis;
  • Myocardial infarction;
  • Sudden cardiac death.
• Myocarditis – Inflammation of the myocardium can affect the heart’s pumping function
• Pericarditis – Inflammation of the pericardium (the membrane surrounding the heart)
• Valvular heart disease – Damage to the heart valves, especially the mitral valve
• Cardiac arrhythmias – Heart rhythm disturbances

Besides cardiac complications, Kawasaki disease can also cause:

• Systemic vasculitis, affecting blood vessels throughout the body;
• Persistent joint problems;
• Neurological complications (rare).

It is important to note that the vasculitis characteristic of Kawasaki disease can also affect the blood vessels in the lower limbs. Although less commonly encountered, skin manifestations may occur on the feet, in the form of edema, erythema, or peeling.

The risk of severe complications decreases significantly if treatment is initiated within the first 10 days of disease onset. However, even with prompt treatment, approximately 5% of children with Kawasaki disease may develop coronary aneurysms.

Long-term monitoring of patients who have had Kawasaki disease is essential, even in the absence of acute complications, to prevent and treat any potential late cardiovascular problems.

The relationship between Kawasaki disease and COVID-19

The COVID-19 pandemic has brought to the attention of researchers a possible link between this viral infection and Kawasaki disease. Clinical observations have shown an increase in Kawasaki disease cases in children during the pandemic, raising questions about the potential relationship between the two conditions. Here are some important aspects to mention:

• Cases of children presenting symptoms similar to Kawasaki disease, as well as manifestations specific to SARS-CoV-2 infection, have been reported
• Some children diagnosed with Kawasaki disease tested positive for COVID-19
• A higher incidence of severe forms of Kawasaki disease was observed among children with COVID-19

Researchers have proposed several hypotheses regarding the mechanism by which COVID-19 could trigger or worsen the child’s illness:

• The systemic inflammatory response in COVID-19 could potentiate the existing inflammatory process in the coronary arteries in Kawasaki disease
• SARS-CoV-2 infection could act as a “trigger” for Kawasaki disease in genetically predisposed children
• Both conditions can cause hyperinflammation, which could explain the observed similarities

It is important to note that while there are similarities between the two conditions, there are also significant differences:

• Age distribution: Kawasaki disease predominantly affects children under 5 years old, while the inflammatory syndrome associated with COVID-19 is more frequent in older children and adolescents
• Clinical manifestations: although both can cause fever and rash, gastrointestinal symptoms are more common in the case of the COVID-19 associated syndrome
• Inflammatory markers: the values of some laboratory parameters, such as ferritin and D-dimer, tend to be higher in the case of COVID-19 associated syndrome

Therefore, although there is evidence of a possible link between Kawasaki disease and COVID-19, further studies on a larger number of patients are needed to confirm and better understand this relationship. Doctors recommend increased attention to symptoms specific to Kawasaki disease in the context of the COVID-19 pandemic, to ensure early diagnosis and appropriate treatment.

The importance of a healthy diet in preventing and managing inflammatory diseases

In the context of inflammatory diseases, such as Kawasaki disease, a healthy and antioxidant-rich diet can play an important role in supporting the immune system and reducing systemic inflammation. In this regard, consuming fruits and vegetables rich in antioxidants is particularly beneficial.

For children with Kawasaki disease or those prone to inflammatory conditions, including Aronia and Siberian Blueberry Juice 3L ECO in their daily diet, under medical supervision, could bring additional benefits in managing the disease and preventing complications. It is also a 100% natural product, with no added sugar or preservatives. It is obtained by cold pressing, thus preserving all the nutritional properties of the fruits intact.

The product is certified organic, guaranteeing that the fruits were grown without the use of pesticides or other harmful chemicals. This aspect is particularly important in the context of inflammatory diseases, where reducing exposure to toxins and pro-inflammatory substances is essential.

This juice can be consumed as is or diluted with water, depending on preference. For children, it is recommended to start with small amounts and gradually increase the dose, under the guidance of a pediatrician.

Although consuming aronia and siberian blueberry juice cannot replace medical treatment for Kawasaki disease, it can be a valuable adjunct in a holistic approach to health.

Kawasaki disease remains a complex condition, with many aspects still unexplained. However, advances in diagnosis and treatment have significantly improved the prognosis for patients. Here are some key points to remember:

Early diagnosis and prompt treatment are essential for preventing cardiac complications.

Long-term monitoring is necessary for all patients, even after apparent recovery.

A holistic approach, including a healthy and antioxidant-rich diet, can support recovery and overall health.

Natural products such as Aronia and Siberian Blueberry Juice 3L ECO can be included in a balanced diet to support the immune system and reduce inflammation.

[cta_produs style=”style_2″ product=”147599″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/02/Concluzii-si-recomandari_Suc-de-Aronia-si-Afin-Siberian-pahar-cu-suc-decoratiuni.jpg”]

Research continues to better understand the relationship between Kawasaki disease and other conditions, such as COVID-19.

Conclusions

Ultimately, education and awareness are crucial. Parents and healthcare professionals must be vigilant in recognizing the early signs of Kawasaki disease to ensure optimal management and favorable long-term outcomes. Including antioxidant-rich foods and supplements, such as Aronia and Siberian Blueberry Juice, can be beneficial as part of a broader strategy for preventing and managing inflammatory diseases.

References

1. mayoclinic.org/diseases-conditions/kawasaki-disease/symptoms-causes/syc-20354598
2. cdc.gov/kawasaki/about/index.html
3. pmc.ncbi.nlm.nih.gov/articles/PMC7656130/
4. pmc.ncbi.nlm.nih.gov/articles/PMC9312026/

Photo source: shutterstock.com